Enkephalin-based drug design: Conformational analysis of O-linked glycopeptides by NMR and molecular modeling

Tetrahedron Asymmetry

Volumn 11, Issue 1, 2000, Pages 9-25

  Kriss, Caroline T ^a   Lou, Bih Show ^a   Szabò, Lajos Z ^a   Mitchell, Scott A ^a   Hruby, Victor J ^a   Polt, Robin ^a  

^a University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENKEPHALIN DERIVATIVE;

ARTICLE; CHEMICAL MODIFICATION; CONFORMATION; DRUG DESIGN; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; GLYCOSYLATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

EID: 0034001614     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(99)00544-3     Document Type: Article

References (45)

1. Stallone, D. D.; Stunkard, A. J. Obesity. Biological Bases of Brain Function and Disease; Frazer, A.; Molinoff, P.; Winokur, A., Eds.; Raven Press: New York, 1994; pp. 386-403.
2. Zlokovic, B. V.; McComb, J. G.; Perlmutter, L.; Weiss, M. H.; Davson, H. Neuroactive Peptides and Amino Acids at the Blood-Brain Barrier: Possible Implications for Drug Abuse. In Bioavailability of Drugs to the Brain and the Blood-Brain Barrier; Frankenheim, J.; Brown, R. M., Eds.; U. S. Dept. of Health and Human Services: Rockville, MD, 1992; pp. 26-42.
3. De Wied, D. Ann. NY Acad. Sci. 1977, 297, 263-274.
4. Hughes, J.; Smith, T. W.; Kosterlitz, H. W.; Fothergill, L. A.; Morgan, B. A.; Morris, H. R. Nature 1975, 258, 577-579.
5. (a) Polt, R.; Porreca, F.; Szabo, L.; Bilsky, E.; Davis, P.; Abbruscato, T.; Davis, T.; Horvath, R.; Yamamura, H.; Hruby, V. Proc. Natl. Acad. Sci. USA 1994, 91, 7114-7118.
6. (b) Tomatis, R.; Marastoni, M.; Balboni, G.; Guerrini, R.; Capasso, A.; Sorrentino, L.; Santagada, V.; Caliendo, G.; Lazarus, L.; Salvadori, S. J. Med. Chem. 1997, 40, 2948-2952.
7. (c) Kihlberg, J. Ahman, J.; Walse, B.; Drakenberg, T.; Nilsson, A.; Soderberg-Ahlm, C.; Bengtsson, B.; Olsson, H. J. Med. Chem. 1995, 38, 161-169.
8. (d) Fisher, J. F; Harrsion, A. W.; Bundy, G. L.; Wilkinson, K. F.; Rush, B. D.; Ruwart, M. J. J. Med. Chem. 1991, 34, 3140-3143.
9. (e) Rodriguez, R. E.; Rodriguez, F. D.; Sacristan, M. P.; Torres, J. L.; Valencia, G.; Garcia, A. Neuroscience Lett. 1989, 101, 89-94.
10. (f) Polt, R. L.; Porecca, F.; Szabo, L.; Hrubv, V. J. Glycoconj. J. 1993, 10, 261.
11. (g) Bardaji, E.; Torres, J. L.; Clapes, P.; Albericio, F.; Barany, G.; Rodriguez, R. E.; Sacristan, M. P.; Valencia, G. J. Chem. Soc., Perkin Trans. 1 1991, 1755-1759.
12. (h) Varga-Degterdarovic, L.; Horvat, S.; Chung, N. N.; Schiller, P. W. Int. J. Pept. Protein Res. 1992, 39, 12-17.
13. (i) Lavielle, S.; Ling, N.; Brazeau, P.; Benoit, R.; Wasada, T.; Harris, D.; Unger, R.; Guillmen, R. Biochem. Biophys. Res. Commun. 1979, 91, 614-622.
14. (j) Geiger, R.; Koning, W.; Sandow, J. Peptides: Chemistry, Biology, Interactions with Proteins; Penke, B.; Torok, A., Eds.; Proceedings of the 50th Anniversary Symposium of the Nobel Prize of Albert Szent-Gyorgi; Walter de Gruyter & Co.: Berlin, 1988; pp. 385-392.
15. (k) Gobbo, M.; Biondi, L.; Filira, F.; Scolaro, B.; Rocchi, R.; Piek, T. Int. J. Pept. Protein Res. 1992, 40, 54-61.
16. (l) Negri, L.; Lattanzi, R.; Tabacco, F.; Scolaro, B.; Rocchi, R. Brit. J. Pharm. 1998, 124, 1516-1522.
17. (m) Negri, L.; Lattanzi, R.; Tabacca, F.; Orrù, L.; Severini, C.; Scolaro, B.; Rocchi, R. J. Med. Chem. 1999, 42, 400-404.
18. Montreuil, J. Adv. Carbohydr. Chem. Biochem. 1980, 37, 157-223.
19. (a) Shogren, R.; Gerken, T. A.; Jentoft, N. Biochemistry 1989, 28, 5525-5536.
20. (b) Butenhof, K. J.; Gerken T. A. Biochemistry 1993, 32, 2650-2663.
21. Maeji, N. J.; Inoue, Y.; Chujo, R. Biopolymers 1987, 26, 1753-1767.
22. Hollosi, M.; Perczel, A.; Fasman, G. D. Biopolymers, 1990, 29, 1549-1564.
23. Andreotti, A. H.; Kahne, D. J. Am. Chem. Soc. 1993, 115, 3352-3353.
24. Kessler, H.; Matter, H.; Gemmecker, G.; Kottenhahn, M.; Bats, J. W. J. Am. Chem. Soc. 1992, 114, 4805-4818.
25. Williams, S. A.; Abbruscato, T. J.; Szabo, L.; Polt, R.; Hruby, V.; Davis, T. P. Biology and Physiology of the Blood-Brain Barrier; Couraud & Scherman, Eds.; Plenum Press: New York, 1996; pp. 69-77.
26. Spellerberg, B.; Prasad, S.; Cabellos, C.; Burroughs, M.; Cahill, Pl.; Toumanen, E. J. Exp. Med. 1995, 182, 1037-1044.
27. (a) Gunther, H. NMR Spectroscopy; John Wiley & Sons: New York, 1995.
28. (b) Cavanagh, J.; Fairbrother, W. J.; Palmer III, A. G.; Skelton, N. J. Protein NMR Spectroscopy Principles and Practice; Academic Press: San Diego, 1996.
29. (c) Wuthrich, K. NMR of Proteins and Nucleic Acids; John Wiley & Sons: New York, 1986.
30. Duben, A. J.; Bush, C. A. Arch. Biochem. Biophys. 1983, 225, 1-15.
31. Bax, A.; Davis, D. G. J. Magn. Reson. 1985, 63, 207-231.
32. Mohamadi, F.; Richards, N. G.; Guida, W. C.; Liskamp, R.; Lipton, M.; Canfield, C.; Chang, G.; Hendrickson, T.; Still, W. C. J. Comp. Chem. 1990, 11, 440-467.
33. Glennon, T. M.; Zheng, Y. J.; LeGrand, S. M.; Shutzberg, B. A.; Merz Jr., K. M. J. Comp. Chem. 1994, 15, 1019-1040.
34. Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. J. Am. Chem. Soc. 1990, 112, 6127-6129.
35. Shenkin, P. S.; McDonald, D. Q. J. Comp. Chem. 1994, 15, 899-916.
36. (a) Hounsell, E. F.; Davies, M. J.; Renouf, D. V. Glycoconjugate J. 1996, 13, 19-26.
37. (b) Montreuil, J. Adv. Carb. Chem. Biochem., 1980, 37, 157-223.
38. Smith, G. D.; Griffin, J. F. Science 1978, 199, 1214-1216.
39. Egleton, R. D.; Mitchell, S. A.; Polt, R.; Hruby, V. J.; Davis, T. P. Brain Res., submitted for publication.
40. Szabo, L.; Ramza, J.; Langdon, C.; Polt, R. Carbohydr. Res. 1995, 274, 11-28.
41. Polt, R.; Szabo, L.; Treiberg, J.; Li, Y.; Hruby, V. J. Am. Chem. Soc. 1992, 114, 10249-10258.
42. (a) Bax, A.; Davis, D. G. J. Magn. Reson. 1985, 65, 355-360.
43. (b) Braunschweiler, L.; Ernst, R. R. J. Magn. Reson. 1983, 53, 521-528.
44. Kessler, H.; Griesinger, C.; Wagner, K. J. Am. Chem. Soc. 1987, 109, 6927-2933.
45. (c) Kover, K. E.; Prakash, O.; Hruby, V. J. J. Magn. Reson. Chem. 1993, 31, 231-237.